![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Hemorrhagic Fevers, Viral - 25 Studies Found
Enrolling by invitation |
: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever : Viral Hemorrhagic Fever : 2015-06-24 : Drug: Ribavirin |
Enrolling by invitation |
: Ribavirin for Hemorrhagic Fever With Renal Syndrome : Hemorrhagic Fever With Renal Syndrome : 2008-02-13 : Drug: Ribavirin 7 Day multiple dosing regime based on weight and dosage day |
Active, not recruiting |
: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans : Crimean-Congo Hemorrhagic Fever : 2017-01-11 :
|
Withdrawn |
: Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany : Hemorrhagic Fever With Renal Syndrome : 2009-03-24 : Drug: Virazole (Ribavirin) Duration of Subject Participati |
Active, not recruiting |
: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever : Hemorrhagic Fever With Renal Syndrome : 2014-04-14 :
|
Enrolling by invitation |
: Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities :
: 2009-10-08 : Drug: Ribavirin (Virazole) Injection The drug is to be adm |
Completed |
: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever :
: 2012-05-14 :
|
Active, not recruiting |
: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda : Hemorrhagic Fever, Ebola : 2015-01-29 :
|
Recruiting |
: Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi : Ebola Hemorrhagic Fever : 2016-09-14 : Procedure: blood sampling collection It is an observational study; no interventions are planned in the c |
Completed |
: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines : Hemorrhagic Fever With Renal Syndrome : 2011-12-23 : Biological: Vaccine/device combination for prevention of HFRS PUUV DNA Vaccine, 2.0mg/ml TDS-IM injectio |